Close  

3M™ Curos™ Disinfecting Port Protectors

Curos disinfecting port protectors are alcohol-containing caps that twist onto I.V. access points for disinfection and protection. Consistent use of Curos disinfecting caps on I.V. needleless connectors is associated with decreased central line associated bloodstream infections (CLABSIs).

  • Disinfects in 1 minute. Protects ports for up to 7 days.

    Each Curos disinfecting port protector contains 70% isopropyl alcohol (IPA). The IPA bathes the surfaces of the port and disinfects it in 1 minute.


All patients, all access points, all the time.

  • 3M's Curos disinfecting port protectors is the only brand on the market that has offerings to help reduce risks across all intraluminal access points.

  • Circle of Disinfection and Protection
    Select hotspots to learn more

     

     

     

     

    Select hotspots to learn more

Needleless Connectors

3M™ Curos™ Disinfecting Cap for Needleless Connectors

Learn More

Needleless Connectors

3M™ Curos Jet™ Disinfecting Cap for Needleless Connectors

Learn More

Male Luers

3M™ Curos Tips™ Disinfecting Cap for Male Luers

Learn More

Tego® Hemodialysis Connectors

3M™ Curos™ Disinfecting Cap for Tego® Hemodialysis Connectors

Learn More

Stopcock

3M™ Curos™ Stopper Disinfecting Cap for Open Female Luers

Learn More

Catheter Hub

3M™ Curos™ Stopper Disinfecting Cap for Open Female Luers

Learn More

3M™ Curos™ Disinfecting Port Protectors achieved a 99.99% reduction in 6 microbes commonly associated with CLABSI*

  • The effectiveness of Curos disinfecting port protectors was tested in vitro against**: Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Candida albicans, Pseudomonas aeruginosa, and Candida glabrata. All test samples exceeded the minimum 4-log reduction after one minute. (3M data on file.)

3M Curos Microbes Kill Chart

Advantages Over Scrubbing

The traditional standard of care in port disinfection has been a thorough manual scrub of the port with an alcohol pad, often referred to as “scrubbing the hub.“ Curos disinfecting port protectors provide several advantages over the scrub the hub protocol:

  • Nurse using Curos on patient
    Save time

    Curos alcohol-impregnated caps provide fast passive disinfection, saving nurses valuable time compared to most scrub the hub protocols. In addition, no drying time is required to achieve disinfection.

  • Curos laying on a flat surface
    Provide a physical barrier
    They provide a physical barrier to contamination between accesses, for up to 7 days.
  • Curos cap being twisted
    Remove user technique variation

    Once a Curos cap is twisted into place, it provides consistent disinfection.

  • Patient in hospital bed on Curos
    Provide visual confirmation

    Curos caps’ bright color help caregivers verify that a port is clean at a glance.


Infusion Nurses Society (INS) Infusion Therapy Standards of Practice 2021 Update

Standard 36 – Needleless Connectors
Practice Recommendation G
- Disinfect needleless connectors attached to any vascular access device (VAD) to reduce introduction of intraluminal microbes using either active or passive disinfection. Perform passive disinfection by applying a cap or covering containing a disinfection agent. Disinfection caps create a physical barrier to contamination between uses. (Level 1)

Download our Infusion Therapy Standards of Practice eBook to find overviews of new and expanded recommendations.

Society for Healthcare Epidemiology of America (SHEA) 2014 Update
“Use an antiseptic-containing hub/connector cap/port protector to cover connectors.”
(quality of evidence: 1-highest level)


Clinical Evidence

Read the Clinical Evidence

Several hospitals have implemented Curos products with impressive results. Explore the results below by category: infection reduction, improved compliance, financial savings and time savings.


Video Resources

  • Curos Product Trial
    Request a Product Evaluation
  • IV with port protectors
    How to Use Videos
  • People Talking and Connecting
    3M™ Peak™ Clinical Outcomes Program

    The 3M™ Peak™ Clinical Outcomes Program provides you with the resources and partnership you need to define and achieve the outcomes most important to you, your patients and your organization.

  • Antimicrobial Skin Graphic
    Stop Bloodstream Infections Before They Start

    As your partner in protecting patients, we want to do everything in our power to help you achieve your goal of zero bloodstream infections. Learn more about free educational resources and evidence-based products to help you stop bloodstream infections before they start.


Doctor monitors patient in hospital bed on IV

Improve patient outcomes at every touchpoint

As you adapt to shifting infection prevention priorities, we’re here to help every step of the way. Learn about our holistic approach to help reduce risk and protect against vulnerabilities.

VIEW RESOURCES
Read Our Blog
Transforming Outcomes

Explore how science and innovation are transforming the healthcare industry.

READ OUR BLOG

Contact Us

Customer Service
1-800-228-3957

Customer Service
1-800-228-3957



*For more information regarding organisms associated with central line–associated bloodstream infections, refer to:
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., . . . Fridkin, S. (2013). Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infection Control & Hospital Epidemiology, 34(01), 1-14. doi:10.1086/668770
**Data reflects in vitro findings on Curos™ Disinfecting Port Protectors
1. Merrill, et. Al, Impact of Universal Disinfectant Cap Implementation on Central Line-Associated Bloodstream Infections. American Journal of Infection Control. December 2014: Volume 40 (12)
2. Cameron-Watson. Port Protectors in Clinical Practice: An Audit. British Journal of Nursing: (IV Therapy Supplement). 2016: Vol 25 (8)
3. Forcing the Function: Implementation and Evaluation of an IV Port Protector to Decrease CLABSI. Legacy Health, Portland, Oregon: Mary Davis, BSN, RN, CCRN